Viking Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
04 Jan 24 | Sell€245,006 | Gregory Zante | Individual | 15,000 | €16.33 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 18,891 | 0.0171% |
Individual Insiders | 2,336,094 | 2.12% |
Public Companies | 3,616,077 | 3.28% |
General Public | 25,757,978 | 23.4% |
Institutions | 78,539,170 | 71.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
15,004,340 | €1.1b | 0% | 0.07% | |||
7,605,867 | €537.4m | 6.66% | 0.01% | |||
5,732,990 | €405.1m | -10.6% | 0.02% | |||
5,381,904 | €380.3m | 1.85% | 0.01% | |||
5,145,112 | €363.5m | 12.5% | 1.38% | |||
3,673,935 | €259.6m | 3.49% | 0.09% | |||
3,616,077 | €255.5m | 0% | no data | |||
2,243,523 | €158.5m | 5.73% | 0.47% | |||
2,223,822 | €157.1m | 0.98% | 0.09% | |||
2,128,343 | €150.4m | 5.01% | 0.01% | |||
1,870,897 | €132.2m | 6.24% | no data | |||
1,279,000 | €90.4m | 0% | 1.92% | |||
1,269,370 | €89.7m | 80.7% | 0.01% | |||
1,004,386 | €71.0m | 0.1% | 4.5% | |||
916,380 | €64.7m | -1.21% | 0.01% | |||
912,569 | €64.5m | 0% | 0.42% | |||
859,691 | €60.7m | 170% | 0.03% | |||
814,839 | €57.6m | 30.9% | 0.01% | |||
775,699 | €54.8m | 0% | 0.01% | |||
762,448 | €53.9m | 11.2% | 0.03% | |||
750,000 | €53.0m | 0% | 0.95% | |||
694,724 | €49.1m | 6,010% | 0.04% | |||
663,155 | €46.9m | 0% | 0.01% | |||
620,000 | €43.8m | -0.8% | 4.18% | |||
612,274 | €43.3m | 74.2% | 0.02% |